Your browser doesn't support javascript.
loading
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.
Price, James M; Mistry, Hitesh B; Betts, Guy; Cheadle, Eleanor J; Dixon, Lynne; Garcez, Kate; Illidge, Tim; Iyizoba-Ebozue, Zsuzsanna; Lee, Lip Wai; McPartlin, Andrew; Prestwich, Robin J D; Papageorgiou, Savvas; Pritchard, Dylan J; Sykes, Andrew; West, Catharine M; Thomson, David J.
Afiliação
  • Price JM; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Mistry HB; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Betts G; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Cheadle EJ; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
  • Dixon L; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Garcez K; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Illidge T; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Iyizoba-Ebozue Z; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Lee LW; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • McPartlin A; Department of Clinical Oncology, Leeds Cancer Centre, Leeds, United Kingdom.
  • Prestwich RJD; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Papageorgiou S; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Pritchard DJ; Department of Clinical Oncology, Leeds Cancer Centre, Leeds, United Kingdom.
  • Sykes A; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • West CM; Department of Clinical Oncology, Leeds Cancer Centre, Leeds, United Kingdom.
  • Thomson DJ; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
J Clin Oncol ; 40(20): 2203-2212, 2022 07 10.
Article em En | MEDLINE | ID: mdl-35385334
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Orofaríngeas / Cisplatino Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Orofaríngeas / Cisplatino Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido